Northern Trust Corp Axcella Health Inc. Transaction History

Northern Trust Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.16 - $1.1 $2,286 - $15,719	14,290 Added 38.73%	51,187 $16,000
Q3 2022 Nov 14, 2022	BUY	$1.62 - $2.73 $5,456 - $9,194	3,368 Added 10.05%	36,897 $63,000
Q3 2021 Nov 15, 2021	SELL	$2.98 - $4.31 $4,854 - $7,020	-1,629 Reduced 4.63%	33,529 $100,000
Q2 2021 Aug 13, 2021	SELL	$3.08 - $5.13 $429,225 - $714,911	-139,359 Reduced 79.85%	35,158 $141,000
Q1 2021 May 12, 2021	SELL	$4.55 - $6.72 $69,564 - $102,742	-15,289 Reduced 8.06%	174,517 $831,000
Q4 2020 Feb 11, 2021	BUY	$4.24 - $5.97 $71,397 - $100,528	16,839 Added 9.74%	189,806 $985,000
Q3 2020 Nov 16, 2020	BUY	$4.12 - $5.91 $143,165 - $205,366	34,749 Added 25.14%	172,967 $800,000
Q2 2020 Aug 14, 2020	BUY	$2.94 - $7.7 $229,361 - $600,707	78,014 Added 129.58%	138,218 $764,000
Q1 2020 May 14, 2020	BUY	$2.25 - $5.24 $35,547 - $82,786	15,799 Added 35.58%	60,204 $206,000
Q4 2019 Feb 14, 2020	BUY	$3.08 - $5.9 $45,928 - $87,980	14,912 Added 50.56%	44,405 $178,000
Q3 2019 Nov 13, 2019	BUY	$5.25 - $9.26 $104,291 - $183,949	19,865 Added 206.33%	29,493 $167,000
Q2 2019 Aug 13, 2019	BUY	$8.51 - $14.95 $81,934 - $143,938	9,628 New	9,628 $90,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.